Discovery and characterization of a covalent inhibitor of New Delhi metallo β-lactamase
- 7 April 2026
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 781, 110805
Abstract
No abstract availableKeywords
Funding Information
- Center for Scientific Review (R35GM13965 8)
- National Institutes of Health
- Welch Foundation (F-1225)
- Welch Foundation (F-1155)
This publication has 39 references indexed in Scilit:
- Characterization of Lipidated New Delhi Metallo-β-lactamase Using Synthetic NanodiscsBiochemistry, 2025
- Mechanism of Ampicillin Hydrolysis by New Delhi Metallo‐β‐Lactamase 1: Insight From QM/MM MP2 CalculationJournal of Computational Chemistry, 2024
- The Hunt Lab Guide to De Novo Peptide Sequence Analysis by Tandem Mass SpectrometryMolecular & Cellular Proteomics, 2024
- Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1)European Journal of Medicinal Chemistry, 2021
- Recent research and development of NDM-1 inhibitorsEuropean Journal of Medicinal Chemistry, 2021
- Covalent Inhibition in Drug DiscoveryChemMedChem, 2019
- The Taxonomy of Covalent InhibitorsBiochemistry, 2018
- Covalent Inhibition of New Delhi Metallo‐β‐Lactamase‐1 (NDM‐1) by CefaclorChemBioChem, 2014
- The emerging NDM carbapenemasesTrends in Microbiology, 2011
- Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure–activity relationshipBioorganic & Medicinal Chemistry, 2002